Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 126 entries
View as:

First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years

Phase: N/A Priority: Normal
NCT ID: NCT03011528 Org: User:
Start: 12/31/16 End: 11/30/23 Due: 11/30/24

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Phase: N/A Priority: Normal
NCT ID: NCT04118062 Org: User:
Start: 02/02/21 End: 05/26/24 Due: 05/26/25

COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur

Phase: N/A Priority: Normal
NCT ID: NCT04369066 Org: User:
Start: 04/28/20 End: 05/13/22 Due: 05/13/23

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04720729 Org: User:
Start: 04/21/21 End: 04/21/25 Due: 04/21/26

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid

Phase: N/A Priority: Normal
NCT ID: NCT06459791 Org: User:
Start: 12/06/24 End: 09/30/28 Due: 09/30/29

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial

Phase: N/A Priority: Normal
NCT ID: NCT02244125 Org: User:
Start: 04/14/14 End: 05/29/23 Due: 05/29/24

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01334008 Org: User:
Start: 04/30/11 End: 05/31/12 Due: 05/31/13

Optimizing the Care Pathways of Patients Treated for Operable Breast.

Phase: N/A Priority: Normal
NCT ID: NCT02813317 Org: User:
Start: 12/31/14 End: 04/30/17 Due: 04/30/18

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01349842 Org: User:
Start: 03/02/10 End: 11/06/18 Due: 11/06/19

Characterisation of Biofilm of the Chronic Wounds

Phase: N/A Priority: Normal
NCT ID: NCT02519166 Org: User:
Start: 05/31/12 End: 05/31/15 Due: 05/31/16

Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT01448759 Org: User:
Start: 10/31/11 End: 02/29/12 Due: 02/28/13

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

Phase: N/A Priority: Normal
NCT ID: NCT04790682 Org: User:
Start: 05/27/21 End: 06/01/28 Due: 06/01/29

Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds

Phase: N/A Priority: Normal
NCT ID: NCT06581809 Org: User:
Start: 03/27/25 End: 12/30/26 Due: 12/30/27

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Phase: N/A Priority: Normal
NCT ID: NCT05282901 Org: User:
Start: 07/07/22 End: 11/15/26 Due: 11/15/27

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898014 Org: User:
Start: 05/31/07 End: - Due: -

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04775043 Org: User:
Start: 03/23/21 End: 04/11/22 Due: 04/11/23

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses

Phase: N/A Priority: Normal
NCT ID: NCT03739775 Org: User:
Start: 01/24/19 End: 06/01/26 Due: 06/01/27

Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)

Phase: N/A Priority: Normal
NCT ID: NCT01956552 Org: User:
Start: 11/30/09 End: 02/29/16 Due: 02/28/17

Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02250118 Org: User:
Start: 12/09/14 End: 10/17/17 Due: 10/17/18

Conservative Treatments of Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02866136 Org: User:
Start: 02/29/12 End: 09/30/35 Due: 09/30/36

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Phase: N/A Priority: Normal
NCT ID: NCT01868269 Org: User:
Start: 04/18/13 End: 01/17/25 Due: 01/17/26

Study on Skin Toxicities Induced by Cancer Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04402606 Org: User:
Start: 11/25/20 End: 04/15/24 Due: 04/15/25

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04541537 Org: User:
Start: 01/25/21 End: 12/20/21 Due: 12/20/22

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01710605 Org: User:
Start: 02/29/12 End: 09/30/18 Due: 09/30/19

Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)

Phase: N/A Priority: Normal
NCT ID: NCT02842723 Org: User:
Start: 03/31/10 End: 02/02/21 Due: 02/02/22